<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM">
      <PMID Version="1">31183350</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>10</Month>
        <Day>01</Day>
      </DateRevised>
      <Article PubModel="Print">
        <Journal>
          <ISSN IssnType="Print">2307-8960</ISSN>
          <JournalIssue CitedMedium="Print">
            <Volume>7</Volume>
            <Issue>10</Issue>
            <PubDate>
              <Year>2019</Year>
              <Month>May</Month>
              <Day>26</Day>
            </PubDate>
          </JournalIssue>
          <Title>World journal of clinical cases</Title>
          <ISOAbbreviation>World J Clin Cases</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Small cell lung cancer with panhypopituitarism due to ectopic adrenocorticotropic hormone syndrome: A case report.</ArticleTitle>
        <Pagination>
          <StartPage>1177</StartPage>
          <EndPage>1183</EndPage>
          <MedlinePgn>1177-1183</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.12998/wjcc.v7.i10.1177</ELocationID>
        <Abstract>
          <AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Small cell lung cancer (SCLC) accounts for 15% of lung cancers, and it commonly expresses peptide and protein factors that are active as hormones. These secreting factors manifest as paraneoplastic disorders, such as ectopic adrenocorticotropic hormone (ACTH) syndrome (EAS). The clinical features are abnormalities in carbohydrate metabolism, hypokalemia, peripheral edema, proximal myopathy, hypertension, hyperpigmentation, and severe systemic infection. However, it is uncommon that EAS has an influence on hypothalamus-pituitary function.</AbstractText>
          <AbstractText Label="CASE SUMMARY" NlmCategory="METHODS">A 62-year-old man presented with complaints of haemoptysis, polyuria, polydipsia, increased appetite, weight loss, and pigmentation. Following a series of laboratory and imaging examinations, he was diagnosed with SCLC, EAS, hypogonadism, hypothyroidism, and central diabetes insipidus. After three rounds of chemotherapy, levels of ACTH, cortisol, thyroid hormone, gonadal hormone, and urine volume had returned to normal levels. In addition, the pulmonary tumor was reduced in size.</AbstractText>
          <AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">We report a rare case of SCLC complicated with panhypopituitarism due to EAS. We hypothesize that EAS induced high levels of serum glucocorticoid and negative feedback for the synthesis and secretion of antidiuretic hormone from the paraventricular nucleus, and trophic hormones from the anterior pituitary. Therefore, patients who present with symptoms of hypopituitarism, or even panhypopituitarism, with SCLC should be evaluated for EAS.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Jin</LastName>
            <ForeName>Ting</ForeName>
            <Initials>T</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Endocrinology, Zhejiang University School of Medicine Sir Run Run Shaw Hospital, Hangzhou 310016, Zhejiang Province, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Wu</LastName>
            <ForeName>Fang</ForeName>
            <Initials>F</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Endocrinology, Zhejiang University School of Medicine Sir Run Run Shaw Hospital, Hangzhou 310016, Zhejiang Province, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Sun</LastName>
            <ForeName>Shui-Ya</ForeName>
            <Initials>SY</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Endocrinology, Zhejiang University School of Medicine Sir Run Run Shaw Hospital, Hangzhou 310016, Zhejiang Province, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Zheng</LastName>
            <ForeName>Fen-Ping</ForeName>
            <Initials>FP</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Endocrinology, Zhejiang University School of Medicine Sir Run Run Shaw Hospital, Hangzhou 310016, Zhejiang Province, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Zhou</LastName>
            <ForeName>Jia-Qiang</ForeName>
            <Initials>JQ</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Endocrinology, Zhejiang University School of Medicine Sir Run Run Shaw Hospital, Hangzhou 310016, Zhejiang Province, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Zhu</LastName>
            <ForeName>Yi-Ping</ForeName>
            <Initials>YP</Initials>
            <AffiliationInfo>
              <Affiliation>Department of General Surgery, Zhejiang University School of Medicine Sir Run Run Shaw Hospital, Hangzhou 310016, Zhejiang Province, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Wang</LastName>
            <ForeName>Zhou</ForeName>
            <Initials>Z</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Endocrinology, Zhejiang University School of Medicine Sir Run Run Shaw Hospital, Hangzhou 310016, Zhejiang Province, China. 3405008@zju.edu.cn.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D016454">Review</PublicationType>
        </PublicationTypeList>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>World J Clin Cases</MedlineTA>
        <NlmUniqueID>101618806</NlmUniqueID>
        <ISSNLinking>2307-8960</ISSNLinking>
      </MedlineJournalInfo>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Case report</Keyword>
        <Keyword MajorTopicYN="N">Ectopic adrenocorticotropic hormone syndrome</Keyword>
        <Keyword MajorTopicYN="N">Panhypopituitarism</Keyword>
        <Keyword MajorTopicYN="N">Small cell lung cancer</Keyword>
      </KeywordList>
      <CoiStatement>Conflict-of-interest statement: The authors declare that there is no conflict of interest that could be perceived as prejudicing the impartiality of the research reported.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2018</Year>
          <Month>12</Month>
          <Day>29</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2019</Year>
          <Month>3</Month>
          <Day>29</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2019</Year>
          <Month>4</Month>
          <Day>9</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2019</Year>
          <Month>6</Month>
          <Day>12</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2019</Year>
          <Month>6</Month>
          <Day>12</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2019</Year>
          <Month>6</Month>
          <Day>12</Day>
          <Hour>6</Hour>
          <Minute>1</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">31183350</ArticleId>
        <ArticleId IdType="pmc">PMC6547328</ArticleId>
        <ArticleId IdType="doi">10.12998/wjcc.v7.i10.1177</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Yang YN.  Disease of endocrinology system: heterologous endocrine syndrome: ectopic ACTH syndrome. In: Haozhu Chen (ed). Practice of Internal Medicine (12th). People’s Medical Publishing House, Beijing; 2005. pp. 1300–1301 (In Chinese).</Citation>
        </Reference>
        <Reference>
          <Citation>Beuschlein F, Hammer GD. Ectopic pro-opiomelanocortin syndrome. Endocrinol Metab Clin North Am. 2002;31:191–234.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12055989</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Isidori AM, Lenzi A. Ectopic ACTH syndrome. Arq Bras Endocrinol Metabol. 2007;51:1217–1225.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18209859</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Isidori AM, Kaltsas GA, Pozza C, Frajese V, Newell-Price J, Reznek RH, Jenkins PJ, Monson JP, Grossman AB, Besser GM. The ectopic adrenocorticotropin syndrome: clinical features, diagnosis, management, and long-term follow-up. J Clin Endocrinol Metab. 2006;91:371–377.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16303835</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lin CJ, Perng WC, Chen CW, Lin CK, Su WL, Chian CF. Small cell lung cancer presenting as ectopic ACTH syndrome with hypothyroidism and hypogonadism. Onkologie. 2009;32:427–430.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19556823</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kakucska I, Qi Y, Lechan RM. Changes in adrenal status affect hypothalamic thyrotropin-releasing hormone gene expression in parallel with corticotropin-releasing hormone. Endocrinology. 1995;136:2795–2802.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">7789304</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Duick DS, Warren DW, Nicoloff JT, Otis CL, Croxson MS. Effect of single dose dexamethasone on the concentration of serum triiodothyronine in man. J Clin Endocrinol Metab. 1974;39:1151–1154.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">4430708</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Marazuela M, Cuerda C, Lucas T, Vicente A, Blanco C, Estrada J. Anterior pituitary function after adrenalectomy in patients with Cushing's syndrome. Postgrad Med J. 1993;69:547–551.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2399881</ArticleId>
            <ArticleId IdType="pubmed">8415342</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tanaka H, Kobayashi A, Bando M, Hosono T, Tsujita A, Yamasawa H, Ohno S, Hironaka M, Sugiyama Y. [Case of small cell lung cancer complicated with diabetes insipidus and Cushing syndrome due to ectopic adrenocorticotropic hormone secretion] Nihon Kokyuki Gakkai Zasshi. 2007;45:793–798.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18018629</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Huang CH, Chou KJ, Lee PT, Chen CL, Chung HM, Fang HC. A case of lymphocytic hypophysitis with masked diabetes insipidus unveiled by glucocorticoid replacement. Am J Kidney Dis. 2005;45:197–200.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15696461</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
